Summary
The effects of forskolin, an activator of adenylate cyclase, on the release of vasopressin from isolated rat neurointermediate lobes during a 10 min period of potassium stimulation were investigated. Forskolin was added 5 min after the onset of potassium stimulation. A concentration-dependent reduction in the amount of hormone released during the remaining 5 min period of stimulation was observed. The results suggest that an increase in cyclic AMP following depolarisation inhibits hormone release. This contrasts with several other reports showing that an increase in cyclic AMP prior to stimulation enhances release. We therefore propose that cyclic AMP plays a dual role in stimulus-secretion coupling in the neurohypophysis.
This is a preview of subscription content, log in via an institution to check access.
References
Douglas WW, Poisner AM (1964) Stimulus-secretion coupling in a neurosecretory organ: the role of calcium in the release of vasopressin from the neurohypophysis. J Physiol 172:1–18
Dreifuss JJ (1975) A review of neurosecretory granules: Their content and mechanism of release. Ann NY Acad Sci 248:184–201
Gonzales A, Aranda E, Mezzano D, Garrido J (1983) Effects of diterpene forskolin on the release reaction and protein phosphorylation of human platelets. Cell Biochem and Function 1:179–185
Haiech J, Demaille JG (1983) Phosphorylation and the control of calcium fluxes. Phil Trans Roy Soc Lond B 302:91–98
Hathaway DR, Eaton CR, Adelstein RS (1981) Regulation of human platelet myosin light chain kinase by the catalysic subunit of cyclic AMP-dependent protein kinase. Nature 291:252–254
Le Peuch CJ, Haiech J, Demaille JG (1979) Concerted regulation of cardiac sarcoplasmic reticulum calcium transport by cAMP-dependent and calcium-calmodulin-dependent phosphorylation. Biochemistry 18:5150–5157
Markstein R, Digges K, Marshall NR, Starke K (1984) Forskolin and the release of noradrenaline in cerebrocortical slices. Naunyn-Schmiedeberg's Arch Pharmacol 325:17–24
Mathison R, Lederis K (1977) Inhibitory effects of cyclic AMP on vasopressin release from the rat neural lobe in vitro. Mol Cell Endocrinol 9:81–89
Mathison R, Lederis K (1980) A mechanism for adenosine 3′,5′-monophosphate regulation of vasopressin secretion. Endocrinology 106:842–848
Metzger H, Lindner E (1981) The positive inotropic-acting forskolin, a potent adenylate cyclase activator. Arzneimittelforsch 31:1248–1250
Müller HJ, Baer HP (1983) Relaxant effects of forskolin on smooth muscle. Naunyn-Schmiedeberg's Arch Pharmacol 322:78–82
Racké K, Rothländer M, Muscholl E (1982) Isoprenaline and forskolin increase evoked vasopressin release from rat pituitary. Eur J Pharmacol 82:97–100
Seamon K, Daly JW (1981) Forskolin: a unique diterpene activator of cyclic AMP generating systems. J Cyclic Nucleotide Res 7:201–224
Seamon K, Daly JW (1983) Forskolin, cyclic AMP and cellular physiology. Trends in Pharmacol Sci 4:120–123
Seamon K, Padgett W, Daly JW (1981) Forskolin: Unique diterpene activator of adenylate cyclase in membranes and intact cells. Proc Natl Acad Sci USA 28:3363–3367
Vale MR, Hope DB (1982) Cyclic nucleotides and the release of vasopressin from the rat posterior pituitary gland. J Neurochem 39:569–573
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bowman, D., Lategan, T.W. & Hope, D.B. Forskolin inhibits potassium-evoked release of vasopressin from rat neurohypophyses. Naunyn-Schmiedeberg's Arch. Pharmacol. 328, 358–360 (1985). https://doi.org/10.1007/BF00515568
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00515568